| Autor: |
Rozenblit, Mariya, Mun, Sophia, Soulos, Pamela, Kerin Adelson, Pusztai, Lajos, Mougalian, Sarah |
| Rok vydání: |
2021 |
| DOI: |
10.6084/m9.figshare.13667894.v1 |
| Popis: |
Additional file 1 : Supplementary Table 1. Therapy regimens that comprised the four treatment groups: everolimus exemestane, endocrine therapy, endocrine therapy + CDK 4/6i, and chemotherapy. Supplementary Table 2. Hazard ratios for multivariate analysis of survival among patients with advanced breast cancer by second- versus third-line everolimus exemestane treatment receipt. Supplementary Figure 1. a) Median time to next treatment for second-line everolimus exemestane treatment, stratified by prior treatment. b) Median time to next treatment for third-line everolimus exemestane treatment, stratified by prior treatment. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
